share_log

Corvus Pharmaceuticals | SC 13G: Statement of acquisition of beneficial ownership by individuals-Samlyn Capital, LLC(5.1%),Samlyn, LP(5.1%), etc.

Corvus Pharmaceuticals | SC 13G:超过5%持股股东披露文件-Samlyn Capital, LLC(5.1%),Samlyn, LP(5.1%)等

SEC announcement ·  02/14 13:33
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息